# Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

> **NCT00689351** · PHASE2 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 180 (actual)

## Conditions studied

- Pneumococcal Vaccine

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine
- **BIOLOGICAL:** 7-valent pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT00689351
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689351, "Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00689351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*